SUSTAINABLE DEVELOPMENT THROUGH AGRO-TOURISM FOR THE CONSOLIDATION OF AGRICULTURE AND THE ENVIRONMENT

Designed as a necessary association between people and nature, as a new way of development that can support the human progress in time, sustainable development can be seen as a harmonization of interests between present and future generations.Therefore, in order to respond to present needs without compromising the capacity of future generations to meet their own needs, sustainable development planning must be understood as a process unfolding at three different levels: economical - by increasing the exploration and the exploitation of resources, environmental - by avoiding environmental degradation, and social - through jobs growth, traditional crafts, agro-tourism and by strengthening the cultural identity of local communities.These levels are closely linked with the different problems agriculture and environmental are facing; so, in order to have aproper development/performance, a soundmanagement and suitable solutions, we need a national legislative framework that is harmonized with international rules; this condition must be regarded as the first/prerequisite step to be takenfor a sustainable development in the future

Macrophage-derived human resistin is induced in multiple helminth infections and promotes inflammatory monocytes and increased parasite burden.

Parasitic helminth infections can be associated with lifelong morbidity such as immune-mediated organ failure. A better understanding of the host immune response to helminths could provide new avenues to promote parasite clearance and/or alleviate infection-associated morbidity. Murine resistin-like molecules (RELM) exhibit pleiotropic functions following helminth infection including modulating the host immune response; however, the relevance of human RELM proteins in helminth infection is unknown. To examine the function of human resistin (hResistin), we utilized transgenic mice expressing the human resistin gene (hRetnTg+). Following infection with the helminth Nippostrongylus brasiliensis (Nb), hResistin expression was significantly upregulated in infected tissue. Compared to control hRetnTg- mice, hRetnTg+ mice suffered from exacerbated Nb-induced inflammation characterized by weight loss and increased infiltration of inflammatory monocytes in the lung, along with elevated Nb egg burdens and delayed parasite expulsion. Genome-wide transcriptional profiling of the infected tissue revealed that hResistin promoted expression of proinflammatory cytokines and genes downstream of toll-like receptor signaling. Moreover, hResistin preferentially bound lung monocytes, and exogenous treatment of mice with recombinant hResistin promoted monocyte recruitment and proinflammatory cytokine expression. In human studies, increased serum resistin was associated with higher parasite load in individuals infected with soil-transmitted helminths or filarial nematode Wuchereria bancrofti, and was positively correlated with proinflammatory cytokines. Together, these studies identify human resistin as a detrimental factor induced by multiple helminth infections, where it promotes proinflammatory cytokines and impedes parasite clearance. Targeting the resistin/proinflammatory cytokine immune axis may provide new diagnostic or treatment strategies for helminth infection and associated immune-mediated pathology

Mieloma múltiple extra-óseo, un caso con mala evolución ¿es lo usual?

PB-021 Introducción: El mieloma extramedular (MEM) se presenta al diagnóstico en 3-18% de los casos y otro 10-30% lo padecerá en algún en la evolución. Esta presentación de MM se asocia a morfología inmadura, Cg de alto riesgo, escape de cadenas ligeras, disminución en la expresión de CD56y aumento en la expresión de CD44 y CXCR4; con peor pronóstico pese a los avances en el tratamiento. Metodologia: Presentamos el caso de un paciente con diagnóstico de MM IgA K extra óseo con una evolución desfavorable. Diagnóstico inicial en Febrero 2014 ISS I, con plasmocitoma en V, VIII y IX arco costal, recibió tratamiento con VD por 6 ciclos alcanzando RC y posteriormente TASPE y consolidación con Velcade por 6 ciclos. Primer recaída en Ago 2016 con masa en pared torácica sin contacto óseo; escape a CLL K, tratamiento con VRD por 6 ciclos logrando RC y segundo TASPE y mantenimiento con R. Segunda recaída en Mayo 2018 con derrame pleural y ascitis maligna, tratamiento con DVd por 1 ciclo y progresión intratratamiento; cambio a Pomalidomida-Claritromicina- Dexametasona sin respuesta, desarrollo de insuficiencia respiratoria, fallo renal y hepático culminando en su fallecimiento en Agosto 2018. Conclusiones: Acorde a lo reportado, la supervivencia de la paciente fue menor a lo esperado por escalas de riesgo (ER) habitual (ISS) y el grado de respuesta alcanzado con el tratamiento, la SG fue de 54 meses con SLP 31 meses, la supervivencia después de la segunda recaída fue de 3 meses, similar a lo ya descrito (6 meses). Acorde a un estudio realizado por Weinstock el MEM solo 1, 32% de los MEM se manifestaron con enfermedad pleural y derrame, y 0, 62% en peritoneo y ascitis (como en el caso). Al igual que lo reportado, la enfermedad de la paciente presentó liberación de cadenas ligeras. Si bien existe evidencia y ..

No differences in pain scores and treatment response in patients from different socioeconomic areas within the city of Chicago

Background: It is well established that the experience of chronic pain significantly differs among ethnic-racial groups. There is mixed evidence to suggest that societal influences may contribute to pain prevalence among cultural groups and their treatment response. One possible explanation for differences in pain experience are the differences in socioeconomic status among patients with chronic pain. Objective: To determine whether there is any difference in pain scores or treatment responses among patients with different socioeconomic status. Study design: Retrospective analysis. Setting: Outpatient pain clinic. Methods: After approval from the Advocate Healthcare Institutional Review Board, we included 1,149 patients treated for different chronic pain conditions who were followed for at least 12 months. Patients were stratified into quartiles determined by median income according to ZIP code. Results: Of the sampled patients, 207 patients lived in ZIP codes with median incomes \u3e $51,294; 515 in ZIP codes with median incomes between$40,083 and $51,294; 332 in ZIP codes with median incomes between$30,625 and $40,083; and 95 in ZIP codes with median incomes \u3c$30,625. Groups differed in age (P = 0.047), race (P \u3c 0.001), body mass index (BMI) (P = 0.019), utilization of opioid medications (P = 0.011), morphine milligram equivalents (MME) on first visit (P = 0.036), and utilization of membrane stabilizers such as gabapentin (P = 0.019). There were no significant differences among groups in terms of gender (P = 0.531), type of pain experienced (P = 0.679), or time since pain onset (P = 0.174). Groups were treated similarly, with no statistically significant differences in the proportions of patients who had taken various nonopioid medications throughout their treatment course other than membrane stabilizers, the number of patients who received interventional pain management procedures, or MME at last visit. Average pretreatment numeric rating scale pain scores were not significantly different among quartiles (P = 0.079), posttreatment pain scores (P = 0.767), and subjective percent improvement (P = 0.434). Limitations: This is a single center study and may have limitations in extrapolating to the general population. Conclusion: The results of our study show that there are no differences in pain perception or treatment responses in patients from different socioeconomic statuses despite differences among groups in age, BMI, race, utilization of opioid medications, and MME at first visit. Patients at this pain practice appear to have been treated with similar modalities regardless of socioeconomic status

Avisalmvac: evaluation studies of stability and toxicity

In Pasteur Institute laboratories there was developed AVISALMVAC, a vaccine against avian Salmonella, a biological product that contains S. enteritidis and S. typhimurium bacterin, with oil adjuvant. This paper presents the results of the studies regarding the stability and toxicity evaluation of this vaccine stored under conditions recommended by the manufacturer (2-80C) at the end of the period of validity. The vaccine stability was assessed by serological and histopathological analysis of samples from SPF chickens vaccinated with the product at the end of the period of validity. The study of Avisalmvac toxicity was carried out by inoculation of the product or its components on Vero cell monolayer, and the effects were microscopically recorded or by MTT test, applied at 6 days post-inoculation. Antibody titers recorded at 2 and 3 weeks post vaccination demonstrated the vaccine ability (used after an year since manufacture) to induce synthesis of specific antibodies and therefore, the product stability was proven. Histopathological examinations carried out on samples taken at 18 days post vaccinationfrom the vaccination site (skeletal muscle and skin) and spleen, did not show any lesions associated to vaccination with Avisalmvac. The cytotoxicity analysis made by inoculating the vaccine or its components on Vero cell monolayer and the microscopic examination did not record visible cytopathic effects for any vaccine dilutions or vaccine components. The cell metabolism evaluation by MTT assay made at 6 days after vaccine/vaccine components inoculation on Vero monolayer, shown the ability of the vaccine and oil adjuvant to stimulate cell metabolism, and a certain degree of toxicity / inhibition of dehydrogenase metabolism associated to one of emulsifier but at dilutions higher than those used in the vaccine formula

On the role of age of onset and input in early child bilingualism in Greek and Dutch

Although input quantity has been shown to affect language development in bilingual acquisition (e.g., Cobo-Lewis et al. 2002, De Houwer 2008), the relationship between the amount of input and linguistic proficiency is not necessarily direct (e.g., Thordadottir 2008). Furthermore, input effects may be mediated by and interact with other factors. One such factor is age of onset (AO). In particular, it has recently been claimed that the morphosyntactic development of children with AO after 4 years is quantitatively and qualitatively different from those with AO before this age (Meisel 2009). This paper reports on a crosslinguistic study of the acquisition of grammatical gender in English/Dutch and English/Greek bilinguals to examine the effects of input quantity and AO in early child bilingualism